Citation Impact
Citing Papers
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
2002
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
2003
Stimulus‐specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera
1988
Constitutional aneuploidy and cancer predisposition
2009
Cellular and molecular mechanisms of fibrosis
2007 Standout
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
The β-Thalassemias
1999 Standout
Ecological Hypothesis of Dentin and Root Caries
2016 Standout
Evaluation of iron overload
2004
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment
2003
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
1989 StandoutNature
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
2006 Standout
Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes
1987
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
1996 StandoutNobel
Biosynthesis and processing of myeloperoxidase — A marker for myeloid cell differentiation
1988
Matrix Metalloproteinases and Other Matrix Proteinases in Relation to Cariology: The Era of ‘Dentin Degradomics'
2015 Standout
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Iron Chelators for Thalassaemia
1998
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
A Risk-Benefit Assessment of Iron-Chelation Therapy
1997
Sickle-cell disease
2010 Standout
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Differentiation induction therapy of myelodysplastic syndromes
1989
Solubilization of glycosyl-phosphatidylinositol-anchored proteins in quiescent and stimulated neutrophils
1995
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
2011 Standout
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology
2006
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.
1994 Standout
5 Myelodysplastic syndromes
1987
Myeloperoxidase Deficiency
1988
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies
1992
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Antimicrobial polypeptides of human neutrophils
1990
The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation
2003
Interleukin-13 Modulates Collagen Homeostasis in Human Skin and Keloid Fibroblasts
2000
Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development
2022 StandoutNobel
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987
Incidence of soft‐tissue cancers in blacks and whites in New York State
1986
How I treat transfusional iron overload
2012
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2
1992 StandoutNobel
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
THE CAVEOLAE MEMBRANE SYSTEM
1998 Standout
Myeloperoxidase: friend and foe
2005 Standout
Agents that increase the permeability of the outer membrane
1992 Standout
Works of Knud Bendix‐Hansen being referenced
Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission ? and the remission phase in acute myeloid leukaemia
1986
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload
1996
Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype
1995
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma
2000
Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow‐up data
1988
Myeloperoxidase‐Deficient Polymorphonuclear Leucocytes
1983
Myeloperoxidase‐Deficient Polymorphonuclear Leucocytes
1983
Primary myelodysplastic syndrome: Treatment of 6 patients with 13‐cis retinoic acid
1986
13-cis Retinoic acid treatment of myelodysplastic syndromes
1987
Myeloperoxidase‐deficient polymorphonuclear leucocytes (VI): Relation to cytogenetic abnormalities in primary myelodysplastic syndromes
1986
Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum
1997
Dermatofibrosarcoma Protuberans: A Clinico-pathological Study of Nineteen Cases and Review of World Literature
1983
Myeloperoxidase‐deficient polymorphonuclear leucocytes (IV): Relation to FAB‐classification in acute myeloid leukaemia
1985
Myeloperoxidase‐deficient polymorphonuclear leucocytes (V): Relation to FAB‐classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes
1985
Myeloperoxidase‐deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders
1986
Evaluation of neutrophil alkaline phosphatase (NAP) activity in untreated myeloproliferative syndromes and in leukaemoid reactions
1985
Myeloperoxidase‐deficient polymorphonuclear leucocytes (III): Relation to incidence of infection in acute myeloid leukaemia
1984